Update on PSA Testing

Author： Gonzalgo Mark L.   Ballentine Carter H.  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.5, Iss.7, 2007-08, pp. : 737-742

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate Health Index: a valuable addition to PSA testing?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 644, 2012-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

“Drugs on oxygen”: an update and perspective on the role of cytochrome P450 testing in pharmacology

By Tralau Tewes   Luch Andreas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1357-1362

Informa Healthcare

Access to resources Recommend Favorite

Aurora kinase inhibitor patents and agents in clinical testing: an update (2009 –– 10)

By Cheung Chun Hei Antonio   Coumar Mohane Selvaraj   Chang Jang-Yang   Hsieh Hsing-Pang  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 6, 2011-06 ,pp. : 857-884

Informa Healthcare

Access to resources Recommend Favorite

Update on HIV viral-load assays: new technologies and testing in resource-limited settings

By de Mendoza Carmen   Soriano Vincent  

Future Virology, Vol. 4, Iss. 5, 2009-09 ,pp. : 423-430

Future Medicine

Access to resources Recommend Favorite

Prediction of Free PSA, PSA Density and PSA Density Transition Zone in the Outcome of Sextant Prostate Biopsies in Patients with Total PSA between 3 and 15 ng/ml

By Michielsen Dirk P.J.   Braeckman Johan G.   de Reijke Theo M.   Vijverberg Peter L.M.   de la Rosette Jean J.M.C.H.  

UroOncology, Vol. 4, Iss. 2, 2004-06 ,pp. : 71-76

Ashgate Publishing Ltd

Access to resources Recommend Favorite